H2020Индивидуална стипендия2017–2019

NanoZfish · Restoration of motor dysfunction in vivo through nanomaterials based devices

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2017-06-01 → 2019-05-31
Финансиране от ЕС
195 455 €
Участници
1
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Въглеродни наноматериали като графена се тестват за възстановяване на двигателни функции при увреждания на гръбначния стълб. Това е важно, защото болести като амиотрофичната странична склероза затрудняват базови процеси като дишането, говоренето и движението.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Restoration of motor dysfunction in vivo through nanomaterials based devices

Motor function is critical to human survival as it governs fundamental behaviours such as locomotion, breathing, speech, feeding and social interaction. Thus, even minor impairment of motor activity can severely hamper quality of life while major impairments, as occur in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), can be life-threatening. These conditions are characterized by lesions to the spinal cord, a region dedicated to the generation of motor behaviours such as walking and swimming. The spinal cord is composed of central pattern generating circuits, a series of evolutionarily conserved neural networks composed of rhythm-generating interneurons that transmit information directly to the motor neurons that execute muscle contractions. Disruption in the function of interneurons or motor neurons within these circuits can have severe consequences to motor performance and thus survival. Over the past two decades, due to their unique combination of chemical and physical properties, carbon based nanomaterials have garnered increasing interest as tools for biomedical applications in the field of neuroscience. Among these, graphene possess the simplest structure, being formed by a mono-layer of carbon atoms. Other carbon based nanomaterials derive from it, such as graphene oxide (GO), a functionalized form of graphene containing carbon, oxygen, and hydrogen in variable ratios, and carbon nanotubes, cylindrically-shaped nanostructures composed of graphene sheets that are rolled to form hollow tubes. Recent evidence has showed that these nanomaterials are able to interact with cells of the nervous system and to modulate their function. This holds a great potential for the development of a novel class of nanomaterials based therapeutics for the rescue of defects in the brain. However, the effect of these materials on neuronal network in vivo and on animal behaviour has been poorly understood yet. To investigate this issue, we have used larval zebrafish as an in vivo model. Early stage zebrafish are ideally suited for this purpose as they are amenable to a broad range of in vivo methodologies, including patch clamp electrophysiology to characterize the electrical activity of neurons, confocal imaging to examine neuronal morphology and behavioural analysis to study their locomotor activity. The purpose of this project was to use zebrafish models to determine whether carbon based nanomaterials could be exploited for the modulation of spinal neuronal activity and of correlated locomotor behaviour in vivo, with the final aim to explore the potential of these materials as novel therapeutics for the cure of nervous system pathologies.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Spinal cord injury (SCI) and amyotrophic lateral sclerosis (ALS) are nervous system maladies that impair the function of spinal central pattern generators for locomotion. These disorders carry a significant social and economic burden, owing to a lack of effective therapeutic treatments. In the field of nanotechnology, carbon nanotubes (CNT) have shown outstanding promise for the improvement of neuronal function in vitro and are thus ideal candidates for repairing or ameliorating spinal defects associated with these disorders. The ultimate goal of this project is to develop CNT as a tool for restoring motor dysfunctions associated with SCI and ALS. Specifically, I will use zebrafish larvae as an in vivo model for testing the therapeutic efficacy of this innovative class of implantable devices. I will implant CNT and graphene based devices in healthy, spinal cord lesioned and ALS zebrafish models and test their effects on spinal cord function with a range of powerful in vivo techniques. My project will address three specific aims. First, biocompatibility of implanted devices will be assessed using in vivo patch clamping of spinal motoneurons in healthy fish implanted with nanodevices. Second, I will implant CNT into fish that have been subjected to SCI. Nanomaterial-facilitated functional recovery will then be tested with in vivo patch clamping of spinal motor neurons, analysis of locomotor behaviour and confocal microscopy. Finally, I will use similar approaches to determine if implanted CNT can slow or reverse spinal cord defects in a SOD1 mutant zebrafish model of ALS. The project will advance our knowledge in an innovative field of bioscience research and help to inform the development of alternative approaches to the treatment of SCI and ALS. Embedded in an international environment, such as that of the University of Leicester, I will support my research activity through a greater level of independence, with the aim of publishing papers as senior author.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз